Following similar moves by other large firms, Raymond James says quarterly advisor counts aren’t the most meaningful measure ...

Raymond James Financial handily beat Wall Street’s expectations with its latest quarterly results, which benefited from a ...

Raymond James reduced their FY2024 earnings estimates for goeasy in a research report issued to clients and investors on ...

In earnings calls, both Raymond James and Ameriprise cited strong recruiting pipelines as they beat analysts’ income ...

Raymond James analyst Matt Roberts lowered the firm’s price target on Avery Dennison (AVY) to $208 from $218 and keeps an Outperform rating on the shares. A disappointing Intelligent Labels growth ...

BofA analyst Mark McLaughlin raised the firm’s price target on Raymond James (RJF) to $201 from $198 and keeps a Buy rating on the shares.

Raymond James raised the firm’s price target on Boston Scientific (BSX) to $119 from $101 and keeps a Strong Buy rating on the shares. Boston Scientific is still one of the most dynamic companies in ...

Like other wealth managers that have ceased reporting advisor numbers every quarter, Raymond James says the figures have lost ...

JMP Securities analyst Devin Ryan raised the firm’s price target on Raymond James (RJF) to $190 from $175 and keeps an Outperform rating on the ...

Raymond James & Associates Inc. and two of its investment bankers got a temporary restraining order against a former intern ...

Raymond James Financial reported a 19.5% rise in first-quarter profit on Wednesday, bolstered by strong performance in its capital markets and wealth management businesses.

M&A activity gradually picked up in pace over the last 12 months as market conditions improved, CEO Paul Reilly said during an earnings call Wednesday. President Paul Shoukry is scheduled to succeed ...